Latest Development Activity News

Po Valley Energy reported consistent gas production and strong cash flow in Q3 2025, while advancing development plans and a new gas sales agreement in Italy.

Neurizon Therapeutics has secured FDA clearance to resume clinical trials for its lead ALS drug candidate NUZ-001 and strengthened its balance sheet with a $5.2 million capital raise. The company is now poised to enter the pivotal HEALEY ALS Platform Trial, marking a significant step forward in its neurodegenerative disease program.

Apollo Minerals reports encouraging exploration results from its Gabon projects, highlighting significant gold intercepts at Salanie and a substantial zinc-lead target at Kroussou, while navigating funding constraints and ongoing legal challenges in Europe.

Superior Resources has boosted its Greenvale Project area by 56%, revealing exceptional copper-gold-silver assay results and advancing its Steam Engine Gold Project towards production within two years.

GBM Resources has launched a major drilling campaign at its Twin Hills gold project and raised A$40 million to fund exploration and development across its Drummond Basin portfolio.

Carnaby Resources reports strong September quarter progress, including significant high-grade copper-gold drill results, full JV buyout, and a $12.5 million placement to advance its Greater Duchess project.

Bounty Oil & Gas reported a modest $272,000 in oil revenue for Q3 2025, boosted reserves in Queensland, and plans to restart Surat Basin production in 2026 while navigating ongoing legal challenges offshore Sydney.

Verity Resources reports robust Phase 1 drilling results at its Monument Gold Project, secures full ownership of Botswana copper-silver assets, and confirms significant rare earth mineralisation in Brazil, underpinning its growth strategy.

West Cobar Metals reports significant progress across its WA and NSW projects, with promising assay results for rare earths and base metals, alongside strategic engagement in the US market and a recent $1.25 million capital raise.

PainChek has secured FDA De Novo clearance for its Adult App, opening immediate access to a $175 million AUD US long-term care market and advancing its Infant App commercialization targeting a $15 billion AUD global opportunity.

Top End Energy has unveiled a significant prospective hydrogen resource in Kansas and strengthened its U.S. market presence with new OTCQB listings, while advancing strategic discussions in Australia’s Beetaloo Basin.

QMines Limited has completed the acquisition of the Mt Mackenzie gold-silver project, upgraded its resource base, and advanced drilling at Develin Creek, supported by a $9 million capital raise to fund exploration and development.